COCRYSTAL PHARMA, INC. Capital Units, Authorized
COCRYSTAL PHARMA, INC. (COCP) had Capital Units, Authorized of 101.00 million shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Equity
us-gaap:CapitalUnitsAuthorized · last filed 2026-03-31
- 2025-12-31: Capital Units, Authorized 101.00M shares.
- 2025-03-31: Capital Units, Authorized 101.00M shares.
- 2024-12-31: Capital Units, Authorized 101.00M shares.
- 2024-09-30: Capital Units, Authorized 101.00M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2025-12-31 | 101.00M shares 10-K · filed 2026-03-31 |
| 2025-03-31 | 101.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 101.00M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 101.00M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 101.00M shares 10-Q · filed 2024-08-14 |
| 2024-06-27 | 155.00M shares 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |